Literature DB >> 22192137

Should all women with PCOS be treated for insulin resistance?

John C Marshall1, Andrea Dunaif.   

Abstract

PRO--A large majority of women with PCOS have insulin resistance, compensatory hyperinsulinemia with consequent reproductive and metabolic abnormalities. Metformin has been shown to be effective therapy and could be used more widely in obese adolescents with hyperandrogenemia, a forerunner of PCOS. CON--The severity of insulin resistance is highly variable in women with PCOS and may not be clinically relevant in milder phenotypes. Treatment should be directed at specific metabolic or reproductive problems and insulin sensitizing drugs are not always the optimum therapy.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22192137      PMCID: PMC3277302          DOI: 10.1016/j.fertnstert.2011.11.036

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  68 in total

1.  Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.

Authors:  C A Eagleson; M B Gingrich; C L Pastor; T K Arora; C M Burt; W S Evans; J C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.

Authors:  Christopher R McCartney; Susan K Blank; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Kristin D Helm; Richard Yoo; R Jeffrey Chang; Carol M Foster; Sonia Caprio; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

Review 3.  Impaired fasting glucose and impaired glucose tolerance: implications for care.

Authors:  David M Nathan; Mayer B Davidson; Ralph A DeFronzo; Robert J Heine; Robert R Henry; Richard Pratley; Bernard Zinman
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

Review 4.  Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.

Authors:  M Costello; B Shrestha; J Eden; P Sjoblom; N Johnson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 5.  Clinical review: Identifying children at risk for polycystic ovary syndrome.

Authors:  Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2006-12-19       Impact factor: 5.958

6.  Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.

Authors:  Thomas M Barber; John A H Wass; Mark I McCarthy; Stephen Franks
Journal:  Clin Endocrinol (Oxf)       Date:  2007-04       Impact factor: 3.478

Review 7.  The metabolic syndrome in polycystic ovary syndrome.

Authors:  Paulina A Essah; Edmond P Wickham; John E Nestler
Journal:  Clin Obstet Gynecol       Date:  2007-03       Impact factor: 2.190

8.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

9.  Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.

Authors:  Richard S Legro; Huiman X Barnhart; William D Schlaff; Bruce R Carr; Michael P Diamond; Sandra A Carson; Michael P Steinkampf; Christos Coutifaris; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Linda C Giudice; Phyllis C Leppert; Evan R Myers
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

10.  Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

Authors:  A Michael Lincoff; Kathy Wolski; Stephen J Nicholls; Steven E Nissen
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

View more
  34 in total

1.  The Effect of Sleeve Gastrectomy on the Hormonal Profile of Patients with Polycystic Ovary Syndrome.

Authors:  Agostinho S Machado Júnior; Cláudio B L Ribeiro; Fernando Santa-Cruz; Brena F Sena; Jose-Luiz Figueiredo; Álvaro A B Ferraz; Josemberg M Campos
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 2.  A review on inositol's potential in cyclic disturbances of adipose-endocrinology-associated polycystic ovary syndrome.

Authors:  Waleed Hassan Almalki
Journal:  Mol Cell Biochem       Date:  2021-03-23       Impact factor: 3.396

3.  Effect of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: long-term follow-up of an RCT.

Authors:  Renyuan Li; Tingting Mai; Siyuan Zheng; Ying Zhang
Journal:  Arch Gynecol Obstet       Date:  2022-07-13       Impact factor: 2.493

4.  Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome.

Authors:  M Rizzo; E K Tyndall; S Frontoni; F Jacoangeli; F Sarlo; F Panebianco; A Mistorni; L Di Renzo; R Calafiore; G Luca; A De Lorenzo
Journal:  J Endocrinol Invest       Date:  2013-04-23       Impact factor: 4.256

Review 5.  Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Liuting Zeng; Kailin Yang
Journal:  Endocrine       Date:  2017-10-19       Impact factor: 3.633

Review 6.  Associations Between Serum Magnesium Concentrations and Polycystic Ovary Syndrome Status: a Systematic Review and Meta-analysis.

Authors:  Maedeh Babapour; Hamed Mohammadi; Maryam Kazemi; Amir Hadi; Mahsa Rezazadegan; Gholamreza Askari
Journal:  Biol Trace Elem Res       Date:  2020-08-18       Impact factor: 3.738

7.  Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome.

Authors:  Büşra Başar Gökcen; Yasemin Akdevelioğlu; Sultan Canan; Nuray Bozkurt
Journal:  Eat Weight Disord       Date:  2020-08-08       Impact factor: 4.652

8.  Chronic inflammation in polycystic ovary syndrome: A case-control study using multiple markers.

Authors:  Soumik Goswami; Subhadip Choudhuri; Basudev Bhattacharya; Rana Bhattacharjee; Ajitesh Roy; Satinath Mukhopadhyay; Sujoy Ghosh; Subhankar Chowdhury
Journal:  Int J Reprod Biomed       Date:  2021-04-22

Review 9.  Resveratrol and Markers of Polycystic Ovary Syndrome: a Systematic Review of Animal and Clinical Studies.

Authors:  Sara Shojaei-Zarghani; Maryam Rafraf
Journal:  Reprod Sci       Date:  2021-07-26       Impact factor: 2.924

Review 10.  Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.

Authors:  Joselyn Rojas; Mervin Chávez; Luis Olivar; Milagros Rojas; Jessenia Morillo; José Mejías; María Calvo; Valmore Bermúdez
Journal:  Int J Reprod Med       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.